Clinical Trial Update: Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tolerability, safety, and preliminary efficacy of SAD448 in subjects with ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension

Drugs mentioned

• SAD-448 (SAD-448)

Snippet

Sponsor: Novartis | Conditions: Ocular Hypertension | Phase 1 | Status: COMPLETED